Another Disappointing Study For Fish Oil Supplements
Another large study has failed to find any benefits for fish oil supplements. The Italian Risk and Prevention Study, published in the New England Journal of Medicine, enrolled 12,513 people who had not had a myocardial infarction but had evidence of atherosclerosis or had multiple cardiovascular risk factors. The patients were randomized to either a fish oil supplement (1 gram daily of n-3 fatty acids) or placebo. After 5 years of followup, the primary endpoint– the time to death from cardiovascular causes or admission to the hospital for cardiovascular causes– had occurred in 11.7% of the fish oil More&...
Source: CardioBrief - May 8, 2013 Category: Cardiology Authors: Larry Husten Tags: Heart Failure Heart Rhythms Prevention, Epidemiology & Outcomes Alpha-Linolenic acid Atherosclerosis Cardiovascular disease Docosahexaenoic acid Fatty acid Fish oil Omega-3 fatty acid Source Type: blogs
From Snake Oil to Fish Oil. The Need for a New Approaches to Off-Label Communication
Yesterday the new Duke-Margolis Center for Health Policy (headed by Mark McClellan), held a conference titled, “Off Label Communication in 2016: Meeting Information Needs through New Policy Options.” Those new options are detailed in an important new paper: Policy Options for Off-Label Communication: Supporting Better Information, Better Evidence, and Better Care. Just about every speaker pointed to the need for FDA leadership – though bold action and … clarity. This is urgent for many reasons: different federal agencies (FDA, FTC, DOJ) with different views on pathways and jurisdiction, and the extreme danger of al...
Source: drugwonks.com Blog - September 6, 2007 Category: Pharmaceuticals Source Type: blogs
